AMGN
AMGEN INC
NASDAQ · Healthcare · Drug Manufacturers - General · US
$461.26
−0.90%Price chart
Oct 5Oct 8Oct 13Oct 16Oct 21Oct 26Oct 29Nov 3
Key dataNov 3, 2026
Open$463.38
From 52W high−1.02%
Volume2.35M
Market cap$249.37B
P/E (TTM)28.4x
P/S (TTM)6.5x
Div yield2.15%
Key dataNov 3, 2026
Open
$463.38
From 52W high
−1.02%
Volume
2.35M
Market cap
$249.37B
ValuationView details →
P/E (Fwd)
19.1x
EV/EBITDA
16.6x
P/E (TTM)
28.4x
RSI (14)
70.5
MomentumView details →
1D Return
−0.90%
YTD Return
+42.06%
SummaryUpdated Sep 1, 2026
Amgen Inc. (NASDAQ:AMGN) is one of the world's largest independent biotechnology companies, founded in 1980 and headquartered in Thousand Oaks, California. The company went public in 1983 and has grown to become a leading developer and manufacturer of human therapeutics focused on serious illnesses. Amgen operates globally, serving healthcare providers including physicians, dialysis centers, hospitals, and pharmacies through pharmaceutical wholesale distributors and direct channels. The company has built its reputation on innovative biotechnology medicines, particularly in areas where few treatment options previously existed.
Similar companies
Latest newsMore news →
AMGEN INC reported quarterly earnings of $6.45 per share, above the Zacks Consensus Estimate of $5.74 and compared with $5.64 per share a year earlier.15h agoAMGEN INC reported third-quarter adjusted earnings per share of $6.45, above the $5.77 estimate.17h agoAMGEN INC shares rose 1.97% to $460.73 on the latest trading day.6d ago